2m 2m 2m 2m 2m 2m 2m
ARS Pharma (SPRY)
NASDAQ
$10.27-$0.01 (-0.14%)
Price as of Jun 23, 2026 7:59 PM EDT- $991.0MMarket Cap
- -39.77%1-Year Change
- BiotechnologyIndustry
ARS Pharma (SPRY)
$10.27-$0.01 (-0.14%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 10.94% | 10.9M | 0 (0.00%) | Mar 31, 2026 |
ORBIMED ADVISORS LLC | 8.35% | 8.3M | 0 (0.00%) | Mar 31, 2026 |
RUBRIC CAPITAL MANAGEMENT LP | 8.06% | 8.0M | +1.8M (+22.50%) | Mar 31, 2026 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7.56% | 7.5M | 0 (0.00%) | Mar 31, 2026 |
MILLENNIUM MANAGEMENT LLC | 6.02% | 6.0M | +2.8M (+47.04%) | Mar 31, 2026 |
BLACKROCK, INC. | 5.05% | 5.0M | -73,063 (-1.46%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 4.61% | 4.6M | +328,517 (+7.18%) | Dec 31, 2024 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
iSHARES TRUST | 2.50% | 2.5M | -64,612 (-2.60%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 2.50% | 2.5M | +40,664 (+1.64%) | Mar 31, 2026 |
SPDR SERIES TRUST | 2.23% | 2.2M | +298,708 (+13.49%) | Mar 31, 2026 |
Tekla Healthcare Opportunities Fund | 1.80% | 1.8M | +365,896 (+20.51%) | Mar 31, 2026 |
FRANKLIN STRATEGIC SERIES | 1.62% | 1.6M | +730,778 (+45.49%) | Jan 31, 2026 |
TEKLA HEALTHCARE INVESTORS | 1.56% | 1.5M | +132,264 (+8.54%) | Mar 31, 2026 |
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 1.08% | 1.1M | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions617.4M (93.85%)
- Mutual Funds22.4M (3.40%)
- Insiders18.0M (2.74%)
- Other0 (0.00%)
Insider Transactions
- 2.74% (18.0M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 6Number of InsiderSelling (last 12 months)
- $185.8MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Tanimoto Sarina CHIEF MEDICAL OFFICER | Award | Jan 02, 2026 | $0.00 | 240,000 | $0.00 | 240,000 |
Fitzpatrick Alexander A Chief Legal Officer | Award | Jan 02, 2026 | $0.00 | 240,000 | $0.00 | 240,000 |
Scott Kathleen D. Chief Financial Officer | Award | Jan 02, 2026 | $0.00 | 240,000 | $0.00 | 240,000 |
Lowenthal Richard E PRESIDENT AND CEO | Award | Jan 02, 2026 | $0.00 | 875,000 | $0.00 | 875,000 |
Tanimoto Sarina CHIEF MEDICAL OFFICER | Award | Jan 02, 2026 | $0.00 | 875,000 | $0.00 | 875,000 |
Dorsey Brian Chief Operating Officer | Award | Jan 02, 2026 | $0.00 | 240,000 | $0.00 | 240,000 |
Lowenthal Richard E PRESIDENT AND CEO | Award | Jan 02, 2026 | $0.00 | 240,000 | $0.00 | 240,000 |
Chakma Justin Chief Business Officer | Award | Jan 02, 2026 | $0.00 | 240,000 | $0.00 | 240,000 |
Karas Eric Chief Commercial Officer | Award | Jan 02, 2026 | $0.00 | 240,000 | $0.00 | 240,000 |
Dorsey Brian Chief Operating Officer | Exempt | Nov 13, 2025 | $0.00 | 21,828 | $0.00 | 0 |
Dorsey Brian Chief Operating Officer | Exempt | Nov 13, 2025 | $13,969.92 | 21,828 | $0.64 | 32,617 |
Dorsey Brian Chief Operating Officer | Sell | Nov 13, 2025 | $190,049.85 | 21,828 | $8.71 | 10,789 |
Chakma Justin Chief Business Officer | Exempt | Nov 12, 2025 | $0.00 | 30,000 | $0.00 | 89,047 |
Shah Pratik | Gift | Nov 12, 2025 | $0.00 | 250,000 | $0.00 | 4.6M |
Chakma Justin Chief Business Officer | Exempt | Nov 12, 2025 | $25,200.00 | 30,000 | $0.84 | 166,380 |
Shah Pratik | Gift | Nov 12, 2025 | $0.00 | 100,000 | $0.00 | 4.5M |
Chakma Justin Chief Business Officer | Sell | Nov 12, 2025 | $267,357.00 | 30,000 | $8.91 | 136,380 |
Chakma Justin Chief Business Officer | Sell | Nov 12, 2025 | $1.2M | 136,380 | $8.86 | 0 |
Lowenthal Richard E PRESIDENT AND CEO | Sell | Aug 21, 2025 | $724,345.00 | 50,000 | $14.49 | 1.2M |
Scott Kathleen D. Chief Financial Officer | Exempt | Aug 21, 2025 | $0.00 | 12,500 | $0.00 | 739,830 |
Scott Kathleen D. Chief Financial Officer | Exempt | Aug 21, 2025 | $18,750.00 | 12,500 | $1.50 | 22,542 |
Scott Kathleen D. Chief Financial Officer | Sell | Aug 21, 2025 | $187,500.00 | 12,500 | $15.00 | 10,042 |
Karas Eric Chief Commercial Officer | Exempt | Jul 01, 2025 | $0.00 | 15,000 | $0.00 | 544,588 |
Karas Eric Chief Commercial Officer | Exempt | Jul 01, 2025 | $22,500.00 | 15,000 | $1.50 | 25,315 |
Karas Eric Chief Commercial Officer | Sell | Jul 01, 2025 | $254,860.50 | 15,000 | $16.99 | 10,315 |
Flynn James E | Sell | Jun 27, 2025 | $6.8M | 370,075 | $18.46 | 4.9M |
Flynn James E | Sell | Jun 27, 2025 | $6.8M | 370,074 | $18.46 | 4.9M |
Kelly Michael | Award | Jun 25, 2025 | $0.00 | 30,000 | $0.00 | 30,000 |
Islam Saqib | Award | Jun 25, 2025 | $0.00 | 30,000 | $0.00 | 30,000 |
Thompson Peter A. | Award | Jun 25, 2025 | $0.00 | 30,000 | $0.00 | 30,000 |